Terms: = Small Cell Lung Cancer AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2 AND Diagnosis
112 results:
1. Ultrasonic-responsive piezoelectric stimulation enhances sonodynamic therapy for her2-positive breast cancer.
Chen Z; Yang L; Yang Z; Wang Z; He W; Zhang W
J Nanobiotechnology; 2024 Jun; 22(1):369. PubMed ID: 38918812
[TBL] [Abstract] [Full Text] [Related]
2. Prolonged Response to Afatinib and Crizotinib in a Rare Case of
Plomer E; Früh M; Lauber A; Demmer I; Jochum W; Koster KL
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891886
[TBL] [Abstract] [Full Text] [Related]
3. Regional differences in predictive biomarker testing rates for patients with metastatic NSCLC in the Netherlands.
de Jager VD; Cajiao Garcia BN; Kuijpers CCHJ; de Bock GH; Maas WJ; Timens W; van Kempen LC; van der Wekken AJ; Schuuring E; Willems SM
Eur J Cancer; 2024 Jul; 205():114125. PubMed ID: 38788285
[TBL] [Abstract] [Full Text] [Related]
4. Comprehensive genomic profiling of pulmonary spindle cell carcinoma using tissue and plasma samples: insights from a real-world cohort analysis.
Sun Y; Qin S; Wang S; Pang J; Ou Q; Liang W; Zhong H
J Pathol Clin Res; 2024 May; 10(3):e12375. PubMed ID: 38661052
[TBL] [Abstract] [Full Text] [Related]
5. An odd dancing couple. Non-small cell lung carcinoma with coexisting EGFR mutation and NTRK-1 translocation: A case report.
Robledano R; Lozano MD
Diagn Cytopathol; 2024 Jul; 52(7):393-396. PubMed ID: 38634549
[TBL] [Abstract] [Full Text] [Related]
6. Factors influencing blood tumor marker concentrations in the absence of neoplasia.
Trapé J; Fernández-Galán E; Auge JM; Carbonell-Prat M; Filella X; Miró-Cañís S; González-Fernández C;
Tumour Biol; 2024; 46(s1):S35-S63. PubMed ID: 38517826
[TBL] [Abstract] [Full Text] [Related]
7. Synchronous double primary small cell lung cancer and invasive ductal breast carcinoma: a case report.
Gan J; Liu M; Liu F; Wen J; Fu W; Jia J
BMC Pulm Med; 2024 Feb; 24(1):93. PubMed ID: 38388422
[TBL] [Abstract] [Full Text] [Related]
8. miRNA-449c-5p regulates the JAK-STAT pathway in inhibiting cell proliferation and invasion in human breast cancer cells by targeting erbb2.
Li L; Zhang Y; Yang K; Liu W; Zhou Z; Xu Y
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1974. PubMed ID: 38351535
[TBL] [Abstract] [Full Text] [Related]
9. Deciphering the heterogeneity of neutrophil cells within circulation and the lung cancer microenvironment pre- and post-operation.
Liu F; Liu X; Liu Y; Chen D; Liu X; Qin C; Song Y; Fang H; Wu D
Cell Biol Toxicol; 2024 Feb; 40(1):11. PubMed ID: 38319415
[TBL] [Abstract] [Full Text] [Related]
10. Comparison of Clinicopathogenomic Features and Treatment Outcomes of EGFR and her2 Exon 20 Insertion Mutations in Non-small cell lung cancer: Single-Institution Experience.
Lee SH; Jeong H; Kim DH; Jang SJ; Kim SW; Yoon S; Lee DH
Cancer Res Treat; 2024 Jul; 56(3):774-784. PubMed ID: 38291744
[TBL] [Abstract] [Full Text] [Related]
11. Detection and Monitoring of Tumor-Derived Mutations in Circulating Tumor DNA Using the UltraSEEK lung Panel on the MassARRAY System in Metastatic Non-small cell lung cancer Patients.
Leest PV; Janning M; Rifaela N; Azpurua MLA; Kropidlowski J; Loges S; Lozano N; Sartori A; Irwin D; Lamy PJ; Hiltermann TJN; Groen HJM; Pantel K; Kempen LCV; Wikman H; Schuuring E
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686200
[TBL] [Abstract] [Full Text] [Related]
12. Analysis of rare fusions in NSCLC: Genomic architecture and clinical implications.
Seker-Cin H; Tay TKY; Kazdal D; Kluck K; Ball M; Neumann O; Winter H; Herth F; Heußel CP; Savai R; Schirmacher P; Thomas M; Budczies J; Allgäuer M; Christopoulos P; Stenzinger A; Volckmar AL
Lung Cancer; 2023 Oct; 184():107317. PubMed ID: 37586177
[TBL] [Abstract] [Full Text] [Related]
13. [Advances in diagnosis and Treatment of her2-positive Non-small cell lung cancer].
Ren C; Cao H; Zheng J; Sun W; Zhou J
Zhongguo Fei Ai Za Zhi; 2023 Apr; 26(4):291-302. PubMed ID: 37183644
[TBL] [Abstract] [Full Text] [Related]
14. Analyses of single extracellular vesicles from non-small lung cancer cells to reveal effects of epidermal growth factor receptor inhibitor treatments.
Stridfeldt F; Cavallaro S; Hååg P; Lewensohn R; Linnros J; Viktorsson K; Dev A
Talanta; 2023 Jul; 259():124553. PubMed ID: 37084607
[TBL] [Abstract] [Full Text] [Related]
15. [New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology].
Isla D; Lozano MD; Paz-Ares L; Salas C; de Castro J; Conde E; Felip E; Gómez-Román J; Garrido P; Belén Enguita A
Rev Esp Patol; 2023; 56(2):97-112. PubMed ID: 37061248
[TBL] [Abstract] [Full Text] [Related]
16. Frequent Overexpression of HER3 in Brain Metastases from Breast and lung cancer.
Tomasich E; Steindl A; Paiato C; Hatziioannou T; Kleinberger M; Berchtold L; Puhr R; Hainfellner JA; Müllauer L; Widhalm G; Eckert F; Bartsch R; Heller G; Preusser M; Berghoff AS
Clin Cancer Res; 2023 Aug; 29(16):3225-3236. PubMed ID: 37036472
[TBL] [Abstract] [Full Text] [Related]
17. Novel her2-Targeted Peptide for NIR-II Imaging of Tumor.
Cao R; Li R; Shi H; Liu H; Cheng Z
Mol Pharm; 2023 Feb; 20(2):1394-1403. PubMed ID: 36668683
[TBL] [Abstract] [Full Text] [Related]
18. New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
Isla D; Lozano MD; Paz-Ares L; Salas C; de Castro J; Conde E; Felip E; Gómez-Román J; Garrido P; Enguita AB
Clin Transl Oncol; 2023 May; 25(5):1252-1267. PubMed ID: 36571695
[TBL] [Abstract] [Full Text] [Related]
19. Chinese expert consensus on the diagnosis and treatment of her2-altered non-small cell lung cancer.
Zhang S; Wang W; Xu C; Zhang Y; Cai X; Wang Q; Song Z; Li Z; Yu J; Zhong W; Wang Z; Liu J; Liu A; Li W; Zhan P; Liu H; Lv T; Miao L; Min L; Lin G; Huang L; Yuan J; Jiang Z; Pu X; Rao C; Lv D; Yu Z; Li X; Tang C; Zhou C; Zhang J; Guo H; Chu Q; Meng R; Liu X; Wu J; Zhou J; Zhu Z; Pan W; Dong X; Pang F; Wang K; Yao C; Lin G; Li S; Yang Z; Luo J; Jia H; Nie X; Wang L; Zhu Y; Hu X; Xie Y; Lin X; Cai J; Xia Y; Feng H; Wang L; Du Y; Yao W; Shi X; Niu X; Yuan D; Yao Y; Kang J; Zhang J; Zhang C; Gao W; Huang J; Zhang Y; Sun P; Wang H; Ye M; Wang D; Wang Z; Wan B; Lv D; Yu G; Shi L; Xia Y; Gao F; Zhang X; Xu T; Zhou W; Wang H; Liu Z; Yang N; Wu L; Wang Q; Wang G; Hong Z; Wang J; Fang M; Fang Y; Zhang Y; Song Y; Ma S; Fang W; Lu Y
Thorac Cancer; 2023 Jan; 14(1):91-104. PubMed ID: 36444143
[TBL] [Abstract] [Full Text] [Related]
20. Construction of IMMS Containing Multi-site Liposomes for Dynamic Monitoring of Blood CTC in Patients with Osimertinib-resistant Non-small-cell lung cancer and its Mechanism.
Chen X; Luo L; Lu Y; Qiu Y; Liang J; Chen Y; Ning Y; Li B
Anticancer Agents Med Chem; 2023; 23(6):676-686. PubMed ID: 36345240
[TBL] [Abstract] [Full Text] [Related]
[Next]
